GLN-Ursodiol · DIN 02426900 · 250 mg · tablet
Limited Use, Reason for Use code 273, 534 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 273, 534 required
Write on scriptone applicable Reason for Use code, 273 or 534 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 273, 534
Reason for Use code 273
For the treatment of primary biliary cirrhosis.
Coverage limit:
LU Authorization Period: Indefinite
Reason for Use code 534
For the treatment of primary sclerosing cholangitis.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
GLN-Ursodiol · DIN 02426900
Manufacturer: Glenmark Pharmaceuticals Canada Inc.; listing date 2016-06-29
Health Canada: Marketed since 2021-07-23 · brand GLN-URSODIOL · ATC A05AA02 URSODEOXYCHOLIC ACID · form Tablet · route Oral · ingredients URSODIOL 250 MG · company Glenmark pharmaceuticals canada inc. · schedule Prescription
GLN-Ursodiol: Formulary list price $0.38 per unit (the source does not state the unit; exact figure $0.3818). What the ministry pays, not the patient.
Ministry pays: $0.3818 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02426900)
Source record
DIN 02426900: GLN-Ursodiol
Raw flags: sec12=Y, sec3=Y
Item: 920000308; group id 976; item number 2312; lccId 00141; manufacturer id GLP
Source form: Tab; strength: 250mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $0.3818; ministry $0.3818
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02426900
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=91144
Interchangeable products
AG-Ursodiol · DIN 02505363 · $0.3818
Jamp-Ursodiol · DIN 02472392 · $0.3818
NRA-Ursodiol · DIN 02544032 · $0.3818
PMS-Ursodiol C · DIN 02273497 · $0.3818
Urso · DIN 02238984 · not recorded
Ursodiol C · DIN 02515520 · $0.3818
Shortage status: resolved shortage (ended March 11, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02426900
Shortage record checked October 6, 2026